RE:RE:RE:RE:RE:RE:RE:Relax timeLiked2Think wrote: I have super high expectation for this stock but calling for a dollar right now when the last news wasnt good is not a good idea and is setting unrealistic expections even for the rest of this year and likely next.
Saying we should be equivalent to MIR is also a mistake. Do I think Stage has a better approach than MIR and have a better plan? yes but the fact of the matter we are at $0.095 a share right now and they arent.
Yes i know lots of wood being put on a lot of fires to get this company going but I ask to hold realistic expections and curb the "too the moon" talk we saw on this board after the conference call before we had Q4 results.
Everyone should have known the earnings would not be stellar.Costs money to make money, aka clinical trials and tests. With Covid testing on the radar , a viable partnership and inroad to the US market, as well testing in a controlled group in Western Canada says that someone is doing their job . What is unique of SZLS is their method of testing. MIR does not offer the same, nor does Sona . All IMO. VM .